Assistant Professor, Pediatrics, University of Minnesota Medical School
Neurology
Dr. Peter I. Karachunski, MD
|
|
Give Review
Peter I. Karachunski, MD is an expert in the field of Neurology. He researched medicine at Russian State Medical University. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Peter I. Karachunski is a published MD as well. He has 22 publications published. The latest was: Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Peter Karachunski accepts Medicare payments and is listed with Medicare.gov.
Publications
- Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis.
- Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice.
- Subcutaneous administration of T-epitope sequences of the acetylcholine receptor prevents experimental myasthenia gravis.
- Interleukin-4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4+ epitope sequences of th...
- Myasthenia in SCID mice grafted with myasthenic patient lymphocytes: role of CD4+ and CD8+ cells.
- Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors.
- Nasal administration of synthetic acetylcholine receptor T epitopes affects the immune response to the acetylcholine receptor and prevents experimental myasthenia gravis.
- Immunization of bm12 mice with high doses of acetylcholine receptor overcomes their resistance to experimental autoimmune myasthenia gravis.
- Susceptibility of HLA DR3 transgenic mice to experimental autoimmune myasthenia gravis.
- T cell recognition of the acetylcholine receptor in myasthenia gravis.
- Polymorphism at the HLA-DQ locus determines susceptibility to experimental autoimmune myasthenia gravis.
- Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences.
- Simple, inexpensive computerized rodent activity meters.
- PCR screening of transgenic RAG-2 "knockout" immunodeficient mice.
- Cryptic epitopes on the nicotinic acetylcholine receptor are recognized by autoreactive CD4+ cells.
- Mechanisms by which the I-ABM12 mutation influences susceptibility to experimental myasthenia gravis: a study in homozygous and heterozygous mice.
- Clustering of B and T epitopes within short sequence regions of the nicotinic acetylcholine receptor.
- Residues within the alpha subunit sequence 304-322 of muscle acetylcholine receptor forming autoimmune CD4+ epitopes in BALB/c mice.
- Preferential pairing of T and B cells for production of antibodies without covalent association of T and B epitopes.
- Epitopes on the beta subunit of human muscle acetylcholine receptor recognized by CD4+ cells of myasthenia gravis patients and healthy subjects.
- Adoptive protection from experimental myasthenia gravis with T cells from mice treated nasally with acetylcholine receptor epitopes.
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
Conditions Treated
- Brachial Plexus Injuries
- Brain Injury
- Cerebral Palsy
- Chronic Inflammatory Demyelinating Polyneuritis
- View All
Doctors Specialties
- Neuromuscular Medicine
- Pediatric Neurology
- Neurology
Accepted Insurances
- Choice Plus POS II
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- CHAMPVA
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- First Choice Health
- Golden Rule
- Group Health Cooperative
- HealthPartners
- HealthSmart
- Choice Care PPO
- Medica
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tricare
- Ucare
- Choice Plus POS
- Navigate POS
- Options PPO
- United Healthcare
- Wisconsin Physicians Service
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Minnesota -
Russian State Medical University
Hospital
-
University of Minnesota Medical Center, Fairview
Drug Facts
| NPI NUMBER | 1720176308 | |
| NPPES Provider LastName | KARACHUNSKI | |
| NPPES Provider FirstName | PETER | |
| NPPES Provider ZIPCode | 55455 | |
| NPPES Provider State | MN | |
| Specialty Description | Neurology | |
| Total Claim Count | 418.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 36.0 | |
| Percent Opioid Claims | 8.61 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1720176308 |
| Last Name Of The Provider | KARACHUNSKI |
| First Name Of The Provider | PETER |
| View All |
Similar Doctors
|
Dr. Elizabeth E. Gilles, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Armantina M. Espinosa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. El-Hadi Mouderres, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie E. Hanna, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Timothy J. Feyma, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jesse J. Corry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miles J. Belgrade, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen G. Porth, MD |
|
Dr. Desiree K. Czapansky-Beilman, MD |
|
|
Dr. Terrance D. Capistrant, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald L. Moriarty Jr., MD |
|
Dr. Beverly S. Wical, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Laura C. Speltz, MD |